Serial #90575166
DEAD

Serial Number

90575166

Owner

GRIFOLS DIAGNOSTIC SOLUTIONS INC.

Attorney

Ashly I. Boesche

Filing Date

Mar 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

Serial #90575166 Trademark

Serial Number: 90575166

Serial #90575166 is a trademark filed by GRIFOLS DIAGNOSTIC SOLUTIONS INC. on March 12, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

GRIFOLS DIAGNOSTIC SOLUTIONS INC. (9 trademarks)

EMERYVILLE, CA 94608

Entity Type: 03

Trademark Details

Filing Date

March 12, 2021

Registration Date

Not Registered

Published for Opposition

December 7, 2021

Goods & Services

Custom manufacture of pharmaceutical, veterinary and diagnostic preparations and substances; custom manufacture of biopharmaceuticals; biomanufacturing for others, namely, processing of biopharmaceutical materials for others; consultancy services relating to manufacturing processes for pharmaceutical, veterinary and diagnostic substances; custom manufacture of recombinant proteins

Antibacterial pharmaceuticals; diagnostic veterinary preparations; diagnostic preparations for medical purposes; diagnostic preparations, namely, antigens and antibodies for medical purposes for use in disease testing; pharmaceutical, veterinary and/or diagnostic preparations and substances produced by biochemical and/or genetic engineering methods, namely, antivirals and diagnostic preparations for veterinary and medical use; reagents for medical purposes; tests and test kits for medical and pharmaceutical purposes, namely, drug testing kits comprised of medical diagnostic reagents and assays that testing bodily fluids

Chemical preparations for use in industry; chemicals used in science; reagents for scientific purposes; diagnostic preparations, namely, antigens and antibodies for scientific purposes; testing kits for scientific purposes predominantly consisting of reagents; proteins for industrial use, namely, antigens and antibodies; nucleic acids for laboratory use, namely, nucleic acid for the production of proteins produced by biochemical and/or genetic engineering methods

Scientific and technological services, namely, pharmaceutical and new product research and design; scientific research and development services; research in the chemical, medical, and/or biochemical field; development of pharmaceutical, veterinary medicine and medical diagnostic substances and products and pharmaceutical research regarding methods for the manufacture thereof, namely, using biotechnological and genetically-engineered means; process development services in relation to pharmaceutical, veterinary and diagnostic substances, namely, consulting regarding the development of pharmaceutical preparations and medicines; technical consultancy in the pharmaceutical, veterinary and diagnostic sector, namely, technical consulting in the field of pharmaceutical studies; new product development services in relation to recombinant protein technology and development

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 8, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 8, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 5 GRANTED
May 31, 2024 EX5G
SOU EXTENSION 5 FILED
May 31, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
May 31, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 11, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jan 9, 2024 EX4G
SOU EXTENSION 4 FILED
Jan 9, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 9, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 20, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jul 18, 2023 EX3G
SOU EXTENSION 3 FILED
Jul 18, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 18, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 26, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jan 24, 2023 EX2G
SOU EXTENSION 2 FILED
Jan 24, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 24, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 16, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jul 14, 2022 EX1G
SOU EXTENSION 1 FILED
Jul 14, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 14, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 1, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 7, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 2, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 2, 2021 CRFA
ASSIGNED TO LIE
Oct 26, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 21, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 20, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 20, 2021 GNSL
SUSPENSION LETTER WRITTEN
Oct 20, 2021 CNSL
EXAMINER'S AMENDMENT ENTERED
Oct 20, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 20, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 20, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 20, 2021 CNEA
ASSIGNED TO EXAMINER
Oct 12, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 15, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2021 NWOS
NEW APPLICATION ENTERED
Mar 16, 2021 NWAP